‘They deny the medication that is keeping you alive’: Patients wage grueling legal battles for lifesaving cancer drug
As bureaucratic fights to access Keytruda drag on for years, some patients die waiting.
How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide
The pharmaceutical giant has built a fortress of patents, traded in secrecy and relentlessly lobbied to guard its revenue kingpin Keytruda.
Counterfeiters cash in on the world’s bestselling cancer drug
Desperate patients — and even hospitals — have become unwitting customers of fake Keytruda, with potentially fatal consequences.